Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature

Overview

Journal Curr Cardiol Rev

Publisher Bentham Science Publishers

Specialty Cardiology & Vascular Diseases

Date 2020 Oct 28

PMID 33109063

Citations 14

Authors

Kuldeep Kumar

Nirmal Singh

Amteshwar S Jaggi

Leonid Maslov

Affiliations

Soon will be listed here.

Abstract

Ischemia refers to a reduced supply of oxygen and nutrient to the vital organ of the body. Reperfusion to the ischemic organ is the only way to salvage injury due to ischemia. Paradoxically, reperfusion itself induces the injury, which is more severe than the previous injury referred to as ischemia-reperfusion injury. Ischemia-reperfusion injury is the major cause of mortality in the case of ischemic diseases. The major hurdle for a clinician to treat ischemia is the reperfusion injury, which is encountered in different surgical as well as non-surgical situations. Several therapies, such as anti-platelets, anti-thrombolytic agents have been developed to contain ischemia-reperfusion injury, but with limited success. Over some time, some conditioning techniques such as preconditioning and postconditioning have been used by clinicians to overcome ischemia-reperfusion injury. The present review focuses on the clinical applications of different conditioning techniques in diverse pathological conditions of ischemia-reperfusion injury.

Citing Articles

VRAC channel inhibition as a novel strategy for the treatment of ischemia-reperfusion injury.

Gao Y, Li L, Zhang Y, Chu Y, Han G Front Cell Dev Biol. 2025; 12:1524723.

PMID: 39763586 PMC: 11701159. DOI: 10.3389/fcell.2024.1524723.

Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.

Zhou W, Jiang X, Gao J Asian J Pharm Sci. 2024; 19(6):100965.

PMID: 39640057 PMC: 11617990. DOI: 10.1016/j.ajps.2024.100965.

Amplification of Cardioprotective Response of Remote Ischemic Preconditioning in Rats by Quercetin: Potential Role of Activation of mTOR-dependent Autophagy and Nrf2.

Kandpal A, Kumar K, Singh S, Yadav H, Jaggi A, Singh D Cardiovasc Drugs Ther. 2024; .

PMID: 38916838 DOI: 10.1007/s10557-024-07595-9.

Annexin-A5 monomer as a membrane repair agent for the treatment of renal ischemia-reperfusion injury.

Dong Y, Jia Z, Kang B, Zhang W Mol Biol Rep. 2024; 51(1):679.

PMID: 38796668 DOI: 10.1007/s11033-024-09606-2.

Organ-Specific Mitochondrial Alterations Following Ischemia-Reperfusion Injury in Post-Cardiac Arrest Syndrome: A Comprehensive Review.

Nakamura E, Aoki T, Endo Y, Kazmi J, Hagiwara J, Kuschner C Life (Basel). 2024; 14(4).

PMID: 38672748 PMC: 11050834. DOI: 10.3390/life14040477.

References

Li C, Li Y, Xu M, Wen S, Yao X, Wu Y . Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology. 2013; 118(4):842-52. DOI: 10.1097/ALN.0b013e3182850da5. View

Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M . A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008; 248(6):909-18. DOI: 10.1097/SLA.0b013e31818f3dda. View

Winquist R, Kerr S . Cerebral ischemia-reperfusion injury and adhesion. Neurology. 1997; 49(5 Suppl 4):S23-6. DOI: 10.1212/wnl.49.5_suppl_4.s23. View

Jonassen A, Mjos O, Sack M . p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem Biophys Res Commun. 2004; 315(1):160-5. DOI: 10.1016/j.bbrc.2004.01.029. View

Tong H, Chen W, Steenbergen C, Murphy E . Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res. 2000; 87(4):309-15. DOI: 10.1161/01.res.87.4.309. View

Mocanu M, Baxter G, Yellon D . Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 2000; 130(2):197-200. PMC: 1572087. DOI: 10.1038/sj.bjp.0703336. View

Wu Q, Gui P, Wu J, Ding D, Purusram G, Dong N . Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. -A randomized controlled trial-. Circ J. 2011; 75(8):1885-9. DOI: 10.1253/circj.cj-10-1130. View

Xin P, Zhu W, Li J, Ma S, Wang L, Liu M . Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2010; 298(6):H1819-31. DOI: 10.1152/ajpheart.01102.2009. View

Hu S, Dong H, Li Y, Luo Z, Sun L, Yang Q . Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial. J Neurosurg Anesthesiol. 2009; 22(1):46-52. DOI: 10.1097/ANA.0b013e3181c572bd. View

10.

Darling C, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K . Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol. 2005; 289(4):H1618-26. DOI: 10.1152/ajpheart.00055.2005. View

11.

Staat P, Rioufol G, Piot C, Cottin Y, Cung T, LHuillier I . Postconditioning the human heart. Circulation. 2005; 112(14):2143-8. DOI: 10.1161/CIRCULATIONAHA.105.558122. View

12.

Zhang M, Xu Y, Saini H, Turan B, Liu P, Dhalla N . Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol. 2005; 289(2):H832-9. DOI: 10.1152/ajpheart.00178.2005. View

13.

Lu E, Chen S, Yuan M, Hu T, Zhou H, Luo W . Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg. 1997; 64(5):1320-4. DOI: 10.1016/S0003-4975(97)00838-2. View

14.

Bulluck H, Yellon D, Hausenloy D . Reducing myocardial infarct size: challenges and future opportunities. Heart. 2015; 102(5):341-8. PMC: 4789695. DOI: 10.1136/heartjnl-2015-307855. View

15.

Woo J, Kim W, Ha S, Kim J, Kim S, Kim W . Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol. 2013; 33(9):2252-60. DOI: 10.1161/ATVBAHA.113.301586. View

16.

Mocanu M, Bell R, Yellon D . PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol. 2002; 34(6):661-8. DOI: 10.1006/jmcc.2002.2006. View

17.

Williams T, Waksman R, De Silva K, Jacques A, Mahmoudi M . Ischemic preconditioning-an unfulfilled promise. Cardiovasc Revasc Med. 2015; 16(2):101-8. DOI: 10.1016/j.carrev.2014.12.010. View

18.

Kim W, Lee J, Kim G, Sim H, Kim S . The effect of remote ischemic postconditioning on graft function in patients undergoing living donor kidney transplantation. Transplantation. 2014; 98(5):529-36. DOI: 10.1097/TP.0000000000000098. View

19.

Szocs K . Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys. 2005; 23(3):265-95. View

20.

Carden D, Granger D . Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190(3):255-66. DOI: 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6. View